Tag
NASDAQ: AZN
- Guardant Health gains European CE mark for ESR1 breast cancer test
- Emerging biomarkers may improve early colorectal cancer detection and treatment monitoring
- Illumina partners with pharma giants to map disease biology at unprecedented scale
- Lung Cancer Research Foundation expands 2025 grant program
- Lung cancer awareness month: a Mugglehead roundup
- US government and IonQ partner to build quantum sandbox in space
- Nuvation Bio stock climbs 16.67% on FDA approval of lung cancer drug
- The dual nature of artificial intelligence: A Mugglehead roundup
- Australian biotech uncovers broader view of tumour genetics with liquid biopsy
- AstraZeneca and AI startup join forces in the fight against lung cancer
- South Korean researchers come up with novel treatment option for lung cancer